Lempiäinen, Harri
Brænne, Ingrid
Michoel, Tom http://orcid.org/0000-0003-4749-4725
Tragante, Vinicius
Vilne, Baiba
Webb, Tom R. http://orcid.org/0000-0001-5998-8226
Kyriakou, Theodosios
Eichner, Johannes
Zeng, Lingyao
Willenborg, Christina
Franzen, Oscar http://orcid.org/0000-0002-7573-0812
Ruusalepp, Arno
Goel, Anuj http://orcid.org/0000-0003-2307-4021
van der Laan, Sander W. http://orcid.org/0000-0001-6888-1404
Biegert, Claudia
Hamby, Stephen
Talukdar, Husain A.
Foroughi Asl, Hassan http://orcid.org/0000-0002-6925-9040
Dichgans, Martin
Dreker, Tobias
Graettinger, Mira
Gribbon, Philip
Kessler, Thorsten
Malik, Rainer
Prestel, Matthias
Stiller, Barbara
Schofield, Christine
Pasterkamp, Gerard
Watkins, Hugh
Samani, Nilesh J.
Wittenberger, Timo http://orcid.org/0000-0002-7158-7887
Erdmann, Jeanette http://orcid.org/0000-0002-4486-6231
Schunkert, Heribert
Asselbergs, Folkert W. http://orcid.org/0000-0002-1692-8669
Björkegren, Johan L. M.
,
Article History
Received: 8 August 2017
Accepted: 6 December 2017
First Online: 21 February 2018
Competing Interests
: Harri Lempiäinen is an employee and shareholder of Genedata AG. Johannes Eichner, Claudia Biegert and Timo Wittenberger are employees of Genedata AG. Dr. Bjorkegren and Dr. Michoel are consultants and shareholders in Clinical Gene Networks AB (CGN). Dr. Franzen is part-time employee of CGN. Dr. Björkegren is also chairman of the board of directors in CGN. TRW and NJS are funded by the British Heart Foundation and SEH and NJS by the UK National Institute for Health Research.